Nanomedicine for prion disease treatment: new insights into the role of dendrimers
about
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation.Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer.Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches
P2860
Nanomedicine for prion disease treatment: new insights into the role of dendrimers
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Nanomedicine for prion disease treatment: new insights into the role of dendrimers
@en
type
label
Nanomedicine for prion disease treatment: new insights into the role of dendrimers
@en
prefLabel
Nanomedicine for prion disease treatment: new insights into the role of dendrimers
@en
P2093
P2860
P356
P1433
P1476
Nanomedicine for prion disease treatment: new insights into the role of dendrimers
@en
P2093
James M McCarthy
Jörg Tatzelt
Mark S Rogers
P2860
P304
P356
10.4161/PRI.24431
P577
2013-05-01T00:00:00Z